ADAP News and Press, Adaptimmune Therapeutics plc From 07/22/20

PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q2 2020, before the U.S. markets open on Thursday, August 6, ...

Cancer is one of the most challenging conditions for investigational therapies to target because malignant cells are frequently able to disguise themselves as healthy cells, thereby surpassing detection from the body's immune system. One biotech company that's gaining ground in this field is Ad...

Adaptimmune Therapeutics (NASDAQ: ADAP), a leader in cell therapy to treat cancer, recently closed an underwritten public offering of 20,500,000 of its American Depositary Shares (“ADSs”), including 3,075,000 additional ADSs in accordance with the full exercise of the over-allotm...

Adaptimmune Therapeutics (NASDAQ: ADAP) , a clinical-stage biotech, saw its shares gain an astounding 230% over the month of May, according to data from  S&P Global Market Intelligence . The biotech's shares took flight late last month following a presentation at the Americ...

Adaptimmune Therapeutics (NASDAQ: ADAP ) has priced its public offering of 20.5M American Depositary Shares (“ADSs”) at $11.00/ADS, for expected gross proceeds of ~$225.5M. More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, , Read more ...

Shares of the clinical-stage biotech  Adaptimmune Therapeutics (NASDAQ: ADAP) fell by as much as 11% immediately out of the gate Monday morning. The drugmaker's stock kicked off the week off on a sour note thanks to a fairly large public offering consisting of 12.5 million of its America...

Edwards Lifesciences (NYSE: EW ) -66% . More news on: Edwards Lifesciences Corporation, Iterum Therapeutics plc, Novus Therapeutics, Inc., Stocks on the move, , Read more ...

Adaptimmune Therapeutics (NASDAQ: ADAP ) intends to offer and sell 12.5M American Depositary Shares (ADSs) in a public offering. More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, , Stocks on the move, Read more ...

DENVER, Colo., May 29, 2020 -  Esports  Entertainment Group, (NASDAQ:GMBL), which recently uplisted to the Nasdaq, has been up huge this week, including today’s $1.98 (+36.53%) gain, and currently trading at $7.40. Today’s action appears to be solid follow through on its ...

The following slide deck was published by Adaptimmune Therapeutics plc in conjunction with this Read more ...